The contribution of pharmacokinetic–pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis. - Burgess, D. S.; Frei, C. R.; Lewis II, J. S.; Fiebelkorn, K. R.; Jorgensen, J. H. (Clinical Microbiology & Infection, 2007)